A Postmarketing, Prospective, Multicenter, Observational, Long-Term Safety and Effectiveness Registry Study of Patients With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel (Stargazer)
Latest Information Update: 25 Sep 2024
At a glance
- Drugs Elivaldogene autotemcel (Primary)
- Indications Adrenoleucodystrophy
- Focus Adverse reactions; Therapeutic Use
- Acronyms Stargazer
- Sponsors bluebird bio
- 09 Apr 2024 Status changed from not yet recruiting to recruiting.
- 30 Jan 2024 New trial record